Hi Bripoz,
Lets hope this presentation can clinch us a deal or lead to a crack at a phase 3 approval or bloody something.
We need some direction or we are always in the sights of the traders.
Nice claw back today but by rights we should be around the $1 2o mark imo.
Aloha.
Ann: Viralytics to Present New CAVATAK Clinical Data at AACR, page-7
Add to My Watchlist
What is My Watchlist?